603718 海利生物
已收盘 04-03 15:00:00
资讯
新帖
简况
海利生物(603718)披露控股子公司收购口腔连锁公司股权进展公告,4月3日股价下跌4.53%
证券之星 · 04-03 18:44
海利生物(603718)披露控股子公司收购口腔连锁公司股权进展公告,4月3日股价下跌4.53%
每周股票复盘:海利生物(603718)控股子公司获越南医疗器械注册证
证券之星 · 03-29
每周股票复盘:海利生物(603718)控股子公司获越南医疗器械注册证
海利生物最新公告:控股子公司人工骨产品获越南注册证
证券之星 · 03-27
海利生物最新公告:控股子公司人工骨产品获越南注册证
股市必读:海利生物(603718)3月23日收盘跌5.56%,今年累计跌幅已超20%
证券之星 · 03-24
股市必读:海利生物(603718)3月23日收盘跌5.56%,今年累计跌幅已超20%
海利生物(603718.SH):瑞盛生物可吸收胶原膜产品在越南获得注册证
智通财经网 · 03-20
海利生物(603718.SH):瑞盛生物可吸收胶原膜产品在越南获得注册证
每周股票复盘:海利生物(603718)董事增持35万股
证券之星 · 03-08
每周股票复盘:海利生物(603718)董事增持35万股
海利生物(603718)披露董事兼总经理增持计划实施完毕暨增持股份结果公告,3月2日股价下跌4.1%
证券之星 · 03-02
海利生物(603718)披露董事兼总经理增持计划实施完毕暨增持股份结果公告,3月2日股价下跌4.1%
股市必读:海利生物(603718)今年截至2月13日累计跌幅已超20%
证券之星 · 02-24
股市必读:海利生物(603718)今年截至2月13日累计跌幅已超20%
2月3日海利生物(603718)龙虎榜数据
证券之星 · 02-03
2月3日海利生物(603718)龙虎榜数据
股市必读:海利生物(603718)2月2日收盘跌停,主力净流出1061.77万元
证券之星 · 02-03
股市必读:海利生物(603718)2月2日收盘跌停,主力净流出1061.77万元
每周股票复盘:海利生物(603718)2025年净利预盈1100万至1600万元
证券之星 · 02-01
每周股票复盘:海利生物(603718)2025年净利预盈1100万至1600万元
海利生物(603718)披露公司股票可能被实施退市风险警示的风险提示公告,1月30日股价下跌1.52%
证券之星 · 01-30
海利生物(603718)披露公司股票可能被实施退市风险警示的风险提示公告,1月30日股价下跌1.52%
每周股票复盘:海利生物(603718)完成工商变更及子公司生产许可证更新
证券之星 · 01-25
每周股票复盘:海利生物(603718)完成工商变更及子公司生产许可证更新
海利生物(603718)披露全资子公司医疗器械生产许可证变更公告,01月22日股价上涨0.31%
证券之星 · 01-22
海利生物(603718)披露全资子公司医疗器械生产许可证变更公告,01月22日股价上涨0.31%
海利生物(603718)披露完成工商变更登记公告,1月19日股价上涨0.78%
证券之星 · 01-19
海利生物(603718)披露完成工商变更登记公告,1月19日股价上涨0.78%
每周股票复盘:海利生物(603718)回购注销375.75万股
证券之星 · 01-18
每周股票复盘:海利生物(603718)回购注销375.75万股
海利生物完成部分限制性股票回购注销,总股本缩减至约6.52亿股
中金财经 · 01-13
海利生物完成部分限制性股票回购注销,总股本缩减至约6.52亿股
每周股票复盘:海利生物(603718)拟注销375.75万股限制性股票
证券之星 · 01-11
每周股票复盘:海利生物(603718)拟注销375.75万股限制性股票
海利生物(603718)披露限制性股票回购注销实施公告,1月6日股价下跌1.98%
证券之星 · 01-06
海利生物(603718)披露限制性股票回购注销实施公告,1月6日股价下跌1.98%
每周股票复盘:海利生物(603718)控股子公司拟收购七家口腔连锁公司
证券之星 · 01-02
每周股票复盘:海利生物(603718)控股子公司拟收购七家口腔连锁公司
加载更多
公司概况
公司名称:
上海海利生物技术股份有限公司
所属行业:
医药制造业
上市日期:
2015-05-15
主营业务:
上海海利生物技术股份有限公司的主营业务是体外诊断试剂(IVD)业务板块和口腔组织修复与再生材料业务板块。公司的主要产品是体外诊断试剂、口腔组织修复与再生材料。公司子公司捷门生物被认定为“上海市专精特新中小企业”、“上海市科技小巨人培育企业”,控股子公司瑞盛生物是陕西省瞪羚企业、陕西省“专精特新”中小企业和陕西省工业企业研发机构。
发行价格:
6.81
{"stockData":{"symbol":"603718","market":"SH","secType":"STK","nameCN":"海利生物","latestPrice":4.43,"timestamp":1775199600000,"preClose":4.64,"halted":0,"volume":10344200,"delay":0,"changeRate":-0.0453,"floatShares":649000000,"shares":652000000,"eps":0.2629,"marketStatus":"已收盘","change":-0.21,"latestTime":"04-03 15:00:00","open":4.63,"high":4.63,"low":4.4,"amount":46306700,"amplitude":0.0496,"askPrice":4.44,"askSize":483,"bidPrice":4.43,"bidSize":124,"shortable":0,"etf":0,"ttmEps":0.2629,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775525400000},"marketStatusCode":5,"adr":0,"adjPreClose":4.64,"symbolType":"stock","openAndCloseTimeList":[[1775179800000,1775187000000],[1775192400000,1775199600000]],"highLimit":5.1,"lowLimit":4.18,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":651904700,"isCdr":false,"pbRate":1.88,"roa":"--","peRate":16.850514,"roe":"1.29%","epsLYR":0.27,"committee":0.273736,"marketValue":2888000000,"turnoverRate":0.0159,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-04-08。","floatMarketCap":2875000000},"requestUrl":"/m/hq/s/603718","defaultTab":"news","newsList":[{"id":"2624654645","title":"海利生物(603718)披露控股子公司收购口腔连锁公司股权进展公告,4月3日股价下跌4.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624654645","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624654645?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:44","pubTimestamp":1775213054,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,海利生物报收于4.43元,较前一交易日下跌4.53%,最新总市值为28.88亿元。海利生物于2026年4月3日发布《关于控股子公司收购口腔连锁公司股权的进展公告》。公告显示,公司控股子公司瑞盛生物拟以自有资金6,120万元收购扬州、常州七家口腔连锁公司各51%股权。截至2026年4月1日,常州天宁龙洋金铂利口腔门诊部有限公司已完成工商变更登记,其余公司相关手续仍在办理中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300035934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603718","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623933832","title":"每周股票复盘:海利生物(603718)控股子公司获越南医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2623933832","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623933832?lang=zh_cn&edition=full","pubTime":"2026-03-29 03:07","pubTimestamp":1774724831,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘,海利生物报收于4.62元,较上周的4.5元上涨2.67%。本周,海利生物3月27日盘中最高价报4.62元。本周关注点公司公告汇总:控股子公司人工骨产品获越南D类医疗器械注册证,具备当地销售资格。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","FVNmain","159883","09996","BK0239","603718","BK1100","BK1583","BK1574","09997","BK0046","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622841212","title":"海利生物最新公告:控股子公司人工骨产品获越南注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2622841212","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622841212?lang=zh_cn&edition=full","pubTime":"2026-03-27 17:04","pubTimestamp":1774602285,"startTime":"0","endTime":"0","summary":"海利生物(603718.SH)公告称,公司控股子公司陕西瑞盛生物科技有限公司近日收到越南卫生部通知,其人工骨产品获得D类医疗器械注册证,有效期自2026年3月26日起永久有效。该产品用于颌骨缺损修复,此前已在中国和印度尼西亚获批。此次获批有利于拓展东南亚市场,但尚未形成销售,未来业绩影响存在不确定性。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700034822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","FVNmain","603718","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621085061","title":"股市必读:海利生物(603718)3月23日收盘跌5.56%,今年累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621085061","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621085061?lang=zh_cn&edition=full","pubTime":"2026-03-24 02:23","pubTimestamp":1774290190,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,海利生物报收于4.25元,下跌5.56%,换手率2.84%,成交量18.44万手,成交额8004.86万元。来自交易信息汇总:该股已连续5日下跌,当年累计跌幅29.11%。交易信息汇总股价提醒3月23日海利生物收盘报4.25元,跌5.56%,当日成交1844.02万元。前10个交易日资金流向情况:主力资金累计净流出4648.21万元,股价累计下跌11.77%;融资余额累计减少368.76万元,融券余量累计增加2.9万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400002173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0239","BK0070","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620783013","title":"海利生物(603718.SH):瑞盛生物可吸收胶原膜产品在越南获得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2620783013","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620783013?lang=zh_cn&edition=full","pubTime":"2026-03-20 15:45","pubTimestamp":1773992755,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海利生物 发布公告,公司控股子公司陕西瑞盛生物科技有限公司于2025年12月向越南卫生部递交了瑞盛生物可吸收胶原膜产品的注册申报资料。瑞盛生物于近日收到越南卫生部通知,瑞盛生物的可吸收胶原膜产品获得批准。本次获得越南注册证的可吸收胶原膜是瑞盛生物研发和生产的一种脱细胞基质材料。临床患者牙缺失后,缺牙部位的牙槽骨常因缺乏功能性刺激而发生进行性吸收,进而导致种植牙时面临骨量不足的问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["603718","BK0070","BK0046","BK0239","FVNmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617663586","title":"每周股票复盘:海利生物(603718)董事增持35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663586","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663586?lang=zh_cn&edition=full","pubTime":"2026-03-08 03:13","pubTimestamp":1772910788,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘,海利生物报收于4.86元,较上周的4.88元下跌0.41%。本周,海利生物3月6日盘中最高价报4.86元。股本股东变化高管增减持根据3月2日市场公开信息、上市公司公告及交易所披露数据整理,海利生物最新董监高及相关人员股份变动情况:2026年3月2日公司董事、总经理韩本毅共增持公司股份35.0万股,占公司总股本为0.0537%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800001127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","603718","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616380324","title":"海利生物(603718)披露董事兼总经理增持计划实施完毕暨增持股份结果公告,3月2日股价下跌4.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616380324","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616380324?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:41","pubTimestamp":1772444464,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘,海利生物报收于4.68元,较前一交易日下跌4.1%,最新总市值为30.51亿元。该股当日开盘4.82元,最高4.83元,最低4.6元,成交额达1.27亿元,换手率为4.16%。近日,海利生物发布《董事兼总经理增持计划实施完毕暨增持股份结果公告》。本次增持计划自2026年2月1日起6个月内实施,现已提前完成,符合相关法律法规规定,未导致公司控股股东或实际控制人变化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200026421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0070","603718"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613736545","title":"股市必读:海利生物(603718)今年截至2月13日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613736545","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613736545?lang=zh_cn&edition=full","pubTime":"2026-02-24 01:00","pubTimestamp":1771866041,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘,海利生物报收于4.8元,下跌2.04%,换手率4.62%,成交量30.0万手,成交额1.45亿元。交易信息汇总2月13日海利生物收盘报4.8元,跌2.04%,当日成交3000.1万元。该股已连续4日下跌,当年累计跌幅20.36%。前10个交易日中,主力资金累计净流出1.55亿元,股价累计下跌24.93%;融资余额累计减少5119.46万元,融券余量累计减少3.35万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400006921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0046","603718"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608824513","title":"2月3日海利生物(603718)龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2608824513","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608824513?lang=zh_cn&edition=full","pubTime":"2026-02-03 17:51","pubTimestamp":1770112301,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年2月3日公布的交易公开信息显示,海利生物因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年2月3日收盘,海利生物报收于5.26元,下跌9.93%,已连续跌停2天,换手率1.34%,成交量8.69万手,成交额4568.57万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300031006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0070","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608203899","title":"股市必读:海利生物(603718)2月2日收盘跌停,主力净流出1061.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608203899","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608203899?lang=zh_cn&edition=full","pubTime":"2026-02-03 01:50","pubTimestamp":1770054623,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘,海利生物报收于5.84元,下跌10.02%,跌停,换手率1.3%,成交量8.45万手,成交额4932.29万元。当日关注点来自交易信息汇总:海利生物2月2日收盘报5.84元,跌停,当日成交844.57万元,主力资金净流出1061.77万元,占总成交额21.53%。交易信息汇总股价提醒2月2日海利生物收盘报5.84元,跌停,当日成交844.57万元。前10个交易日资金流向情况:主力资金累计净流出5936.76万元,股价累计下跌9.62%;融资余额累计减少954.6万元,融券余量累计增加1.18万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300001156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0239","BK0046","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608607726","title":"每周股票复盘:海利生物(603718)2025年净利预盈1100万至1600万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608607726","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608607726?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:15","pubTimestamp":1769886914,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,海利生物报收于6.49元,较上周的6.55元下跌0.92%。业绩披露要点海利生物发布业绩预告,预计2025年全年归属净利润盈利1100万元至1600万元,扣非后净利润亏损3.9亿元至4亿元,扣除后营业收入为19,000万元至19,500万元。公司公告汇总上海海利生物技术股份有限公司预计2025年年度实现利润总额3,400万元到4,000万元,归属于母公司所有者的净利润1,100万元到1,600万元,扣除非经常性损益后的净利润为-40,000万元到-39,000万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0070","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607304477","title":"海利生物(603718)披露公司股票可能被实施退市风险警示的风险提示公告,1月30日股价下跌1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607304477","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607304477?lang=zh_cn&edition=full","pubTime":"2026-01-30 23:06","pubTimestamp":1769785581,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,海利生物报收于6.49元,较前一交易日下跌1.52%,最新总市值为42.31亿元。近日,海利生物发布《关于公司股票可能被实施退市风险警示的风险提示公告》。公司已于2026年1月31日发布首次风险提示公告,后续将至少再披露两次。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000048016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","603718","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606373972","title":"每周股票复盘:海利生物(603718)完成工商变更及子公司生产许可证更新","url":"https://stock-news.laohu8.com/highlight/detail?id=2606373972","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606373972?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:26","pubTimestamp":1769282772,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,海利生物报收于6.55元,较上周的6.41元上涨2.18%。本周,海利生物1月23日盘中最高价报6.55元。本周关注点公司公告汇总:海利生物完成工商变更登记,取消监事会,变更注册地址与经营范围,并修订公司章程。海利生物关于全资子公司医疗器械生产许可证变更的公告上海海利生物技术股份有限公司全资子公司上海捷门生物技术有限公司近日收到上海市药品监督管理局换发的《医疗器械生产许可证》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603718","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605497444","title":"海利生物(603718)披露全资子公司医疗器械生产许可证变更公告,01月22日股价上涨0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605497444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605497444?lang=zh_cn&edition=full","pubTime":"2026-01-22 22:32","pubTimestamp":1769092340,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘,海利生物报收于6.47元,较前一交易日上涨0.31%,最新总市值为42.18亿元。公司近日发布公告称,其全资子公司上海捷门生物技术有限公司收到上海市药品监督管理局换发的《医疗器械生产许可证》。本次变更包括许可证有效期延长至2031年1月3日,以及生产地址变更为上海市嘉定区恒裕路66弄1号102室、202室、502室。本次变更系许可证到期延续及生产地址正常变更,对公司生产经营无重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200041038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","09997","BK0070","603718","BK0239","159883","BK1100","BK1222","BK1583","BK0046","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604182857","title":"海利生物(603718)披露完成工商变更登记公告,1月19日股价上涨0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604182857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604182857?lang=zh_cn&edition=full","pubTime":"2026-01-19 17:35","pubTimestamp":1768815319,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘,海利生物报收于6.46元,较前一交易日上涨0.78%,最新总市值为42.11亿元。该股当日开盘6.41元,最高6.47元,最低6.39元,成交额达5096.19万元,换手率为1.22%。近日,海利生物发布关于完成工商变更登记的公告。公告显示,上海海利生物技术股份有限公司已完成工商变更登记,取消监事会,变更注册地址和经营范围,并修订公司章程。公司因限制性股票回购注销,注册资本由655,662,200元变更为651,904,700元,股份总数由655,662,200股变更为651,904,700股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900024000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0239","BK0070","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604923925","title":"每周股票复盘:海利生物(603718)回购注销375.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604923925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604923925?lang=zh_cn&edition=full","pubTime":"2026-01-18 04:00","pubTimestamp":1768680036,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘,海利生物报收于6.41元,较上周的6.48元下跌1.08%。本周,海利生物1月13日盘中最高价报6.8元。本周关注点公司公告汇总:海利生物完成3,757,500股限制性股票回购注销,总股本由655,662,200股变更为651,904,700股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0070","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603522205","title":"海利生物完成部分限制性股票回购注销,总股本缩减至约6.52亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603522205","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603522205?lang=zh_cn&edition=full","pubTime":"2026-01-13 07:58","pubTimestamp":1768262335,"startTime":"0","endTime":"0","summary":"中访网数据 上海海利生物技术股份有限公司于近日完成了2023年股权激励计划中部分限制性股票的回购注销工作。本次回购注销事宜已获得公司董事会审议通过,并履行了通知债权人等法定程序。此次回购注销完成后,公司总股本由655,662,200股减少至651,904,700股,其中有限售条件股份减少至2,925,000股。此次回购注销是基于激励计划相关条款的常规操作,旨在维护公司股权激励制度的严肃性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260113/31935667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0046","603718","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602535496","title":"每周股票复盘:海利生物(603718)拟注销375.75万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2602535496","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602535496?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:07","pubTimestamp":1768072028,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,海利生物报收于6.48元,较上周的6.1元上涨6.23%。本周,海利生物1月5日盘中最高价报6.71元。本周关注点公司公告汇总:海利生物拟回购注销375.75万股限制性股票,涉及离职人员及未达解除限售条件。股本股东变化:本次回购注销后,公司总股本将由655,662,200股减至651,904,700股。其中,离职人员涉及132万股,第二个解除限售期未达标涉及243.75万股。本次回购注销已于2025年10月28日经董事会审议通过,无需提交股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0046","603718"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601813460","title":"海利生物(603718)披露限制性股票回购注销实施公告,1月6日股价下跌1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601813460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601813460?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:28","pubTimestamp":1767709702,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘,海利生物报收于6.45元,较前一交易日下跌1.98%,最新总市值为42.29亿元。公司近日发布公告称,上海海利生物技术股份有限公司因激励对象8人离职及第二个解除限售期条件未成就,决定回购注销限制性股票合计375.75万股。其中,离职人员涉及132万股,第二个解除限售期未达标涉及243.75万股。本次回购注销已于2025年10月28日经董事会审议通过,无需提交股东大会审议。回购注销完成后,公司总股本将由655,662,200股减至651,904,700股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600042576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0046","603718"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600036093","title":"每周股票复盘:海利生物(603718)控股子公司拟收购七家口腔连锁公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2600036093","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600036093?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:33","pubTimestamp":1767295988,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,海利生物报收于6.21元,较上周的6.36元下跌2.36%。海利生物关于控股子公司收购扬州、常州七家口腔连锁公司股权的公告上海海利生物技术股份有限公司控股子公司瑞盛生物拟以自有资金6,120万元收购扬州、常州七家口腔连锁公司各51%股权。本次交易完成后,七家公司将成为瑞盛生物控股子公司,公司二级子公司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603718","BK0070"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775245707596,"stockEarnings":[{"period":"1week","weight":-0.0411},{"period":"1month","weight":-0.0594},{"period":"3month","weight":-0.2738},{"period":"6month","weight":-0.3485},{"period":"1year","weight":-0.4232},{"period":"ytd","weight":-0.2738}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":-0.0496},{"period":"3month","weight":-0.0224},{"period":"6month","weight":-0.0007},{"period":"1year","weight":0.161},{"period":"ytd","weight":-0.0224}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海海利生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"33808人(较上一季度增加7.16%)","perCapita":"19196股","listingDate":"2015-05-15","address":"上海市浦东新区中国(上海)自由贸易试验区临港新片区申港大道133号909室","registeredCapital":"65190万元","survey":" 上海海利生物技术股份有限公司的主营业务是体外诊断试剂(IVD)业务板块和口腔组织修复与再生材料业务板块。公司的主要产品是体外诊断试剂、口腔组织修复与再生材料。公司子公司捷门生物被认定为“上海市专精特新中小企业”、“上海市科技小巨人培育企业”,控股子公司瑞盛生物是陕西省瞪羚企业、陕西省“专精特新”中小企业和陕西省工业企业研发机构。","listedPrice":6.81},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海利生物(603718)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海利生物(603718)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海利生物,603718,海利生物股票,海利生物股票老虎,海利生物股票老虎国际,海利生物行情,海利生物股票行情,海利生物股价,海利生物股市,海利生物股票价格,海利生物股票交易,海利生物股票购买,海利生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海利生物(603718)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海利生物(603718)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}